MedTrace Logo

The Use of Lignocaine and Bupivacaine Mix in Adult Safe Male Circumcision

NCT02245126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2014-09-19

No results posted yet for this study

Summary

Using routinely collected data to compare different concentrations of locally applied anaesthetic drugs and determine which concentrations give better pain control during voluntary medical Male circumcision.

Conditions

  • Post Operative Pain

Interventions

DRUG

3-3-4 mix

the drug mix included lidocaine, bupivacaine and water for injection

DRUG

4-4-2

In this group (4-4-2 group) eligible men were receiving an injection of the 4-4-2 local anesthetic mix ( composed of 4cc of parental lignocaine 2%, 4cc of parental bupivacaine 0.5% and 2cc of water for injection). This mix is given once before commencement of the surgical procedure safe male circumcision.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • International Hospital Kampala

    lead OTHER

Principal Investigators

  • Moses Galukande, MD · International Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02245126 on ClinicalTrials.gov